Moreover, immunoblotting results also indicated that the IDH1 mutation increased GLUD1 expression in OGDH-silenced U87 cells (Fig. 6g), which was consistent with the changes observed in IDH-mutated gliomas (Supplementary Fig. S3c and d). The gene discussed is IDH1; the disease is central nervous system cancer.